About Umang Pharmatech
Umang Pharmatech is a Healthcare company. Encapsulation of materials for pharmaceutical and nutraceutical industries in India. Its Indian entity Umang Global Group Private Limited reported revenue of ₹87.74 Cr. Umang Pharmatech offers products and services including Pellets and Beadlets. Its focus areas include Health and Pharmaceuticals, Nutraceuticals, Nutritional Supplements and Beadlets Production.
Company details
Pellets, beadlets, granules, and spheres are manufactured and exported by the company for the pharmaceutical and nutraceutical sectors, with various formulations including vitamins, amino acids, herbal extracts, and minerals being encapsulated into these forms. The company is positioned as a key producer in India, serving industries through processes that involve active ingredients and drugs. Locations in Mumbai and Vasai, Maharashtra, are utilized for operations, and contact details are provided for inquiries. Essential minerals and proteins are handled in production to meet industry needs, ensuring components are prepared for drug and supplement applications.
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn X Facebook
- Legal Name Umang Global Group Pvt Ltd
- Date of Incorporation 09 Mar, 2020
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹87.74 Cr
FY 2025 · +28% YoY
- Indian entity net profit₹23.43 Cr
FY 2025 · 27% margin
- Indian entity EBITDA₹37.58 Cr
FY 2025 · 43% margin
Associated legal entities of Umang Pharmatech
Umang Pharmatech operates through Umang Global Group Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Umang Global Group Private Limited CIN U24100MH2020PTC338657 | Active | 09 Mar 2020 | Mumbai, Maharashtra | ₹87.7 Cr | 31 | 2 | View details |
Products & Services of Umang Pharmatech
Umang Pharmatech offers a comprehensive portfolio of products and services, including Pellets and Beadlets.
Various materials are encapsulated into pellets for drug delivery in the pharmaceutical sector.
Materials such as vitamins and minerals are encapsulated into beadlets for nutritional applications.
Board of directors of Umang Global Group Private Limited (Umang Pharmatech)
Umang Global Group Private Limited is the primary company behind Umang Pharmatech. The board of Umang Global Group Private Limited currently have 2 directors; the longest-serving is Nidhi Umang Budhraja, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nidhi Umang Budhraja DIN 08719655 | Director | 09 Mar 2020 | 6 yrs 7 mo | Umang Global Group Private Limited |
| Umang Rajkumar Budhraja DIN 08163388 | Director | 09 Mar 2020 | 6 yrs 7 mo | Umang Global Group Private Limited |
Financials of Umang Pharmatech
Figures of Umang Global Group Private Limited, the primary company behind Umang Pharmatech, for FY 2025. Revenue was ₹87.74 Cr (+28% year on year). Net profit was ₹23.43 Cr (27% margin). EBITDA was ₹37.58 Cr (43% margin). Revenue has grown at a compounded annual rate of +269% over three years.
- ₹87.74 CrRevenue · FY 2025 · +28% YoY
- ₹23.43 CrNet profit · 27% margin
- ₹37.58 CrEBITDA · 43% margin
- ₹1.00 CrPaid-up capital
- 31Employees (provident fund records)
- +269%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Umang Global Group Private Limited are on its company page.
Detailed financial statements for Umang Pharmatech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Umang Pharmatech
The primary company behind Umang Pharmatech, Umang Global Group Private Limited, reported revenue of ₹87.74 Cr for FY 2025, up 28% year on year.
Pellets, beadlets, granules, and spheres are manufactured and exported by the company for the pharmaceutical and nutraceutical sectors, with various formulations including vitamins, amino acids, herbal extracts, and minerals being encapsulated into these forms. The company is positioned as a key producer in India, serving industries through processes that involve active ingredients and drugs. Locations in Mumbai and Vasai, Maharashtra, are utilized for operations, and contact details are provided for inquiries. Essential minerals and proteins are handled in production to meet industry needs, ensuring components are prepared for drug and supplement applications.
Umang Pharmatech offers Pellets and Beadlets.
Umang Pharmatech operates through Umang Global Group Private Limited.
The legal entities of Umang Pharmatech currently have 2 directors, including Nidhi Umang Budhraja, Umang Rajkumar Budhraja.